DAMME LAURA 4
4 · TransMedics Group, Inc. · Filed Feb 24, 2022
Insider Transaction Report
Form 4
DAMME LAURA
VP, Clinical Affairs
Transactions
- Award
Stock Option (Right to Buy)
2022-02-22+38,000→ 38,000 totalExercise: $13.28Exp: 2032-02-22→ Common Stock (38,000 underlying)
Footnotes (1)
- [F1]The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026.